What is SynTouch?
Headquartered in Los Angeles and established in 2008, SynTouch occupies a unique niche in the robotics ecosystem. The company is the sole developer of sensor technology capable of replicating, and in specific applications exceeding, the human sense of touch. Its flagship innovation, the BioTac, is engineered to mimic the physical properties and sensory capabilities of a human fingertip. By providing tactile data that allows manufacturers to quantify the haptic qualities of their products, SynTouch has become an essential partner for industries ranging from consumer goods to advanced robotics. The company's proprietary technology bridges the gap between mechanical automation and human-like dexterity, positioning it as a leader in the tactile sensing market.
How much funding has SynTouch raised?
SynTouch has raised a total of $275K across 2 funding rounds:
Debt
$150K
Debt
$125K
Debt (2020): $150K with participation from PPP
Debt (2021): $125K led by PPP
Key Investors in SynTouch
PPP
Public-Private Partnership
What's next for SynTouch?
With the recent influx of capital, SynTouch is well-positioned to scale its operations and deepen its market penetration. The strategic focus will likely shift toward expanding the deployment of BioTac sensors across diverse industrial applications, including medical robotics and advanced manufacturing. By leveraging this late-stage financing, the company aims to refine its sensor architecture and enhance its data analytics capabilities, ensuring that its tactile instrumentation remains the gold standard for sensory feedback. As the robotics sector continues to evolve toward more autonomous and interactive systems, SynTouch is poised to capitalize on the growing necessity for machines that can perceive and interpret the physical world with human-like precision.
See full SynTouch company page
